What is the role of bariatric surgery in treating Type 2 diabetes? Several recent studies explore how weight loss surgery impacts diabetes patient care. Four ways the ACA drives higher-value diabetes care May 28, 2016 By Karen Appold Specific benefits patients with diabetes have experienced due to the ACA, and how those benefits are impacting diabetes costs. Put drug development to work for diabetic patients Although the diabetes pipeline is not large, we continue to have progress in meeting the unmet needs of patients with diabetes. Diabetic patients benefit most from personalized strategies May 01, 2016 By Karen Appold Personalization is the key to a healthcare experience that optimizes outcomes, improves the customer experience and, ultimately, lowers costs to the healthcare system. Find out why it’s especially key for diabetic patients. Undiagnosed diabetes: A high cost for the health system Consequences range from cardiovascular disease to renal disease Strategies to reduce diabetes health management costs March 03, 2016 By Karen Appold Rob Danoff, DO, of Aria Health System, explains what should be done to reduce health management costs, while improving care of diabetic patients. In the pipeline: diabetes care improvements February 02, 2016 By Karen Appold As 2016 gets underway, improvements in diabetes health management are expected to progress. Here are some of the noteworthy trends to watch. 2015: A year of improvements in diabetes management January 15, 2016 By Karen Appold While diabetes, particularly type 2, remains an epidemic, the number of new diagnoses has begun to slow. Here are some developments contributing to the decrease. Lessons learned in the global fight against diabetes Broader exchange of ideas for diabetes health management and related programs may result in more efficient community-based programs with a wider impact. What’s new for diabetes management and prevention From new ways of predicting who will and won’t develop diabetes, to new diabetes meds, to new evidence regarding which anti-vascular endothelial growth factor (VEGF) might be better for your specific patient, the last year has given us better tools for helping our patients with diabetes.